A joint platform combining AI-driven discovery and world-class characterization to accelerate industrial innovation cycles and reduce costs. KREFELD AND BERLIN, GERMANY — Hitachi High-Tech Europe GmbH (“Hitachi”), a wholly owned subsidiary of Hitachi High-Tech Corporation and Dunia Innovations GmbH (“Dunia”), today announced a strategic collaboration to accelerate the discovery, characterization, and industrial deployment of next-generation functional […]
New Cell-Based Assay Supports Drug Discovery Targeting Glucose Homeostasis, Barrier Integrity, and Tissue Repair STATE COLLEGE, PA, UNITED STATES — INDIGO Biosciences, a leading provider of cell-based reporter assay solutions, has announced the launch of its Human GPR39 Reporter Assay. The launch reflects INDIGO’s continued strategy of delivering assays for emerging and relevant drug targets, helping biopharma […]
Werfen, global leader in specialized diagnostics, has announced a strategic collaboration with Oxford Nanopore Technologies to validate Werfen’s specialized transplant assay portfolios for use on Oxford Nanopore’s sequencing platforms. The collaboration combines Werfen’s validated transplant assays with Oxford Nanopore’s sequencing technology to deliver fast, high-resolution results, essential for precise donor-recipient matching. It also streamlines and […]
Seer defends its pioneering Proteograph® Product Suite intellectual property (IP) REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has filed a patent infringement suit against Nanomics Biotechnology Co., Ltd. The asserted patents, U.S. Patent Nos. 11,435,360, 11,630,112, 12,050,222, 12,228,566, and 12,590,948, protect […]
HOUSTON — Elabscience® Bionovation Inc. (“Elabscience®” or “the Company”) today announced the launch of its self-developed PolyHRP-Streptavidin conjugate, a signal amplification reagent designed to improve enzyme-linked immunosorbent assay (ELISA) sensitivity for low-abundance biomarker detection. Using proprietary covalent polymerization technology, the reagent creates a one-to-many amplification structure that strengthens detection signals while maintaining low background interference. Elabscience® developed its […]
Agreement strengthens Aurigene’s discovery platforms with access to foundational CRISPR/Cas9 intellectual property, enabling responsible innovation and enhanced global partner support DUBLIN and BANGALORE, India — ERS Genomics Limited (‘ERS’), the CRISPR licensing company, today announced that it has signed a non-exclusive license agreement with Aurigene Pharmaceutical Services Limited (“Aurigene Services”), an end-to-end integrated global CRDMO […]
BOSTON — Stellaromics, Inc., a leader in 3D spatial multi-omics, today announced two key additions to its executive leadership team: Veronica Mankinen as Senior Vice President of Global Commercial Operations and John Leamon, Ph.D., as Senior Vice President of Product Development. These strategic appointments come as the company ramps up the commercial launch of its Pyxa® […]
New company grows out of ChristianaCare’s Gene Editing Institute to accelerate discovery and innovation WILMINGTON, Del. — ChristianaCare’s Gene Editing Institute has launched DECODR, Inc., a new for‑profit company created to expand access to one of the world’s leading software tools to evaluate the effectiveness of CRISPR gene editing. The software program grew out of the Gene Editing […]
New company grows out of ChristianaCare’s Gene Editing Institute to accelerate discovery and innovation WILMINGTON, Del. — ChristianaCare’s Gene Editing Institute has launched DECODR, Inc., a new for‑profit company created to expand access to one of the world’s leading software tools to evaluate the effectiveness of CRISPR gene editing. The software program grew out of the Gene […]
New kit offers researchers and development teams a meaningful advance in expression speed and output BOSTON — GenScript Biotech Corporation announced the launch of TurboCHO™ Protein Expression Kit, a next-generation antibody expression reagent designed to set a new benchmark for speed, performance, output and ease-of-use. One of the company’s largest global product launches to date, this kit targets the […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
